Anzeige
Mehr »
Login
Donnerstag, 03.04.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Warum Almonty Industries zum Schlüsselplayer für NATO-Staaten wird
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40QA7 | ISIN: US80880X1046 | Ticker-Symbol: 4E4
Frankfurt
02.04.25
16:31 Uhr
1,120 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SCIENTURE HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
SCIENTURE HOLDINGS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,9651,00020:14

Aktuelle News zur SCIENTURE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14:54Scienture Holdings gears up for specialty pharma launches1
14:46Scienture Holdings bereitet sich auf Markteinführungen von Spezialpharmaka vor1
SCIENTURE Aktie jetzt für 0€ handeln
14:30Scienture Holdings, Inc. Issues Annual Letter to Shareholders57TAMPA, FL, April 03, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value...
► Artikel lesen
25.03.Scienture Holdings, Inc.: SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization1
21.03.Scienture Holdings, Inc. - 8-K, Current Report1
19.03.Scienture Holdings announces draw on Equity Line of Credit2
19.03.Scienture Holdings, Inc.: Scienture Holdings Announces Draw on ELOC, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days1
18.03.What's Going On With Scienture Shares Tuesday?1
18.03.Scienture's Arbli Losartan Oral Suspension Gets FDA Approval; Stock Up In Pre-market1
18.03.Scienture Holdings, Inc.: SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was approximately ...216TAMPA, FL, March 18, 2025 (GLOBE NEWSWIRE) -- - SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced...
► Artikel lesen
10.03.Scienture Holdings, Inc. - 8-K, Current Report4
06.03.What's Going On With Scienture Stock Thursday?-
06.03.Pre-market Movers: Visionary Holdings, Scienture, BlackSky Technology, Miller Industries, Interactive Strength668OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.25 A.M. ET).In the Green Visionary Holdings Inc. (GV) is up over 63% at $6.03. Scienture...
► Artikel lesen
06.03.Scienture Holdings, Inc.: SCIENTURE to commercially launch REZENOPY, a life-saving opioid overdose emergency treatment through a collaboration with KINDEVA DRUG DELIVERY L.P.1
06.02.Scienture Holdings, Inc. - S-1/A, General form for registration of securities1
31.01.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 31.01.2025691The following instruments on XETRA do have their first trading 31.01.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 31.01.2025 Aktien 1 CA6699882065 Nu E Power Corp. 2...
► Artikel lesen
30.01.Scienture Holdings, Inc. - S-1/A, General form for registration of securities-
17.01.Scienture Holdings, Inc. - 8-K, Current Report-
14.01.Scienture Holdings, Inc. - S-1/A, General form for registration of securities-
08.01.Scienture Holdings, Inc. - 8-K, Current Report-
Seite:  Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1